BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 25776793)

  • 21. [Chronic lymphocytic leukemia].
    Maurer C; Hallek M
    Dtsch Med Wochenschr; 2013 Oct; 138(42):2153-66. PubMed ID: 24104591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How to Choose the Best Treatment and Testing for Chronic Lymphocytic Leukemia in the Tsunami of New Treatment Options.
    Yeung CCS; Shadman M
    Curr Oncol Rep; 2019 Jul; 21(8):74. PubMed ID: 31327069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chronic lymphocytic leukemia. Treatment and genetic risk profile].
    Stilgenbauer S; Hallek M
    Internist (Berl); 2013 Feb; 54(2):164, 166-70. PubMed ID: 23371259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chronic lymphocytic leukemia: pathophysiology and current therapy].
    Takizawa J
    Rinsho Ketsueki; 2017; 58(5):471-479. PubMed ID: 28592762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
    Abbott BL
    Hematol Oncol; 2005 Mar; 23(1):34-40. PubMed ID: 16149106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chronic lymphocytic leukemia: update on pathophysiology and management].
    Suzumiya J
    Rinsho Ketsueki; 2018; 59(5):511-520. PubMed ID: 29877241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding and managing ultra high-risk chronic lymphocytic leukemia.
    Stilgenbauer S; Zenz T
    Hematology Am Soc Hematol Educ Program; 2010; 2010():481-8. PubMed ID: 21239840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia.
    Innocenti I; Autore F; Pasquale R; Morelli F; Efremov DG; Laurenti L
    Expert Rev Hematol; 2017 Dec; 10(12):1069-1076. PubMed ID: 29082795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic lymphocytic leukemia: state of the art and beyond.
    Byrd JC
    J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):801-3. PubMed ID: 24853221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures.
    Hallek M; Al-Sawaf O
    Am J Hematol; 2021 Dec; 96(12):1679-1705. PubMed ID: 34625994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What Is Optimal Front-Line Therapy for Chronic Lymphocytic Leukemia in 2017?
    Voorhies BN; Stephens DM
    Curr Treat Options Oncol; 2017 Feb; 18(2):12. PubMed ID: 28243993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress in CLL, chemotherapy, antibodies and transplantation.
    Keating MJ
    Biomed Pharmacother; 2001 Nov; 55(9-10):524-8. PubMed ID: 11769960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [News in therapeutic management of chronic lymphoid leukemia].
    Michallet AS; Salles G; Coiffier B; Michallet M
    Bull Cancer; 2005 Mar; 92(3):249-56. PubMed ID: 15820919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk-Adapted Therapy in Early-Stage Chronic Lymphocytic Leukemia.
    Langerbeins P; Groß-Ophoff-Müller C; Herling CD
    Oncol Res Treat; 2016; 39(1-2):18-24. PubMed ID: 26891412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advances in the treatment of chronic lymphocytic leukaemia].
    Mozas P; Delgado J
    Med Clin (Barc); 2016 Nov; 147(10):447-454. PubMed ID: 27431885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An unusual presentation of a chronic lymphocytic leukemia patient with 17p deletion after reduced-intensity transplantation: Richter syndrome and concomitant graft-versus-host disease--case report.
    Salihoglu A; Ozbalak M; Keskin D; Tecimer T; Soysal T; Ferhanoglu B
    Transplant Proc; 2013 Sep; 45(7):2845-8. PubMed ID: 23747187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chronic lymphocytic leukemia: current standards and novel approaches].
    Tausch E; Stilgenbauer S
    Internist (Berl); 2014 Dec; 55(12):1400, 1402-4, 1406-9. PubMed ID: 25392275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolving Strategies for the Treatment of Chronic Lymphocytic Leukemia in the Upfront Setting.
    Bachow SH; Lamanna N
    Curr Hematol Malig Rep; 2016 Feb; 11(1):61-70. PubMed ID: 26951237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic Lymphocytic Leukemia in the Elderly, Which Investigations Are Necessary: A Map for the Practicing Oncologist.
    Pinilla-Ibarz J; Emole J
    Cancer Control; 2015 Oct; 22(4 Suppl):7-16. PubMed ID: 26618341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive and prognostic biomarkers in the era of new targeted therapies for chronic lymphocytic leukemia.
    Rossi D; Gerber B; Stüssi G
    Leuk Lymphoma; 2017 Jul; 58(7):1548-1560. PubMed ID: 27808579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.